Hereditary Cáncer Updates: Lynch Syndrome Book and BRCA Research
Madrid Hosts Hereditary Breast Cancer Meeting on Legal and Ethical Requirements
Specialists in hereditary breast cancer gathered in Madrid on February 16, 2017, for the III Jornada en Cáncer de Mama Hereditario: nuevos retos. The meeting focused on familiarizing medical professionals with the medical, ethical, and legal requirements of patients, as well as new therapeutic opportunities and their implications.
The event was organized by Spain’s two leading breast cancer research groups, Grupo GEICAM and SOLTI, together with the SEOM Hereditary Cancer Section. Coordinators Dr. Judith Balmaña, Dr. Elena Aguirre, and Dr. Iván Márquez considered the meeting of great scientific interest and said it updated knowledge on advances in hereditary cancer.
Summaries of several presentations from the Madrid meeting can be downloaded through the available links.
Asociación Mama y Ovario Hereditario Schedules Barcelona Patient Meeting
Patients and carriers of BRCA1 and BRCA2 mutations will meet in Barcelona on Saturday, May 27, 2017, at the Hotel Olivia Balmes for the II Jornada Cáncermama@ovario hereditario, organized by the Asociación Mama y Ovario Hereditario.
Lynch Syndrome Families Release Free Educational Book
Coinciding with World Lynch Syndrome Day, the Asociación de Familias afectadas por esta enfermedad released a 55-page guide titled Vivir con el síndrome de Lynch. The publication provides affected families, medical professionals, and the general public with research updates, patient testimonials, and specialist advice.
The digital version is available for free download in its entirety. The text covers, in a rigorous and accessible way, everything related to this genetic condition.
Prospective Lynch Syndrome Database Publishes Surveillance Data
The study tracks outcomes for patients undergoing regular preventive screenings.
In addition, Heidi S. Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, and Wendy K. Chung analyzed the clinical impact of panel gene testing for hereditary breast and ovarian cancer.
Those planning a local meeting on hereditary cancer and genetic counseling, or with a particularly relevant or impactful clinical case, can share it at [email protected].